FierceBiotech’s 2019 Fierce 15
Once again, FierceBiotech has honored a group of hard working and cutting-edge biotech companies with their Fierce 15 award. This year they’ve looked outside the U.S. and beyond the oncology and rare disease spaces to include companies in the fields of infectious disease, pain, neurodegenerative disease, and more. Check out their list of up-and-coming biotechs in 2019 below:
- Anthos Therapeutics
- Black Diamond Therapeutics
- Casma Therapeutics
- Celsius Therapeutics
- Confo Therapeutics
- Dewpoint Therapeutics
- Frontier Medicines
- Kymera Therapeutics
- Locus Biosciences
- Maze Therapeutics
- Nkarta Therapeutics
- Nocion Therapeutics
- Prelude Therapeutics
- Quell Therapeutics
- Sanifit